Delivery Order SPE2DB20D3101-SPE2DB22FK2E1

Award Date 6/24/22
Potential Completion Date 6/27/22
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of 4,556,210,488 units of Ciprofloxacin HCL 250 mg tablets to the prime contractor, Amerisourcebergen Drug Corp. The $1,045.02 firm fixed-price delivery order has a completion date of February 10, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.86, is a delivery order for 4,559,295,117 units of Ciprofloxacin HCL 250 MG Tablets. It is a firm-fixed price contract with a completion date of December 8, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $1,846.75 under a Firm Fixed Price contract. The award, made by the Defense Logistics Agency (DLA), is for 4,563,297,065 units of Ciprofloxacin HCL 250 mg tablets with an ultimate completion date of January 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $4,609.20 and awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,248,373 units of Ciprofloxacin HCL 500 mg tablets and has a completion date of September 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.98 Firm Fixed Price Delivery Order contract is for the supply of 4,566,419,843 units of Ciprofloxacin HCL 500 mg tablets. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ciprofloxacin HCL 250 mg tablets. The $8,869.16 Firm Fixed Price Delivery Order was awarded on September 20, 2022 by the Defense Logistics Agency (DLA), with a period of performance through September 21, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.93 firm fixed-price delivery order provides Ciprofloxacin HCL 250 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025 and is not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,481.85 for the supply of 4,558,302,186 units of Ciprofloxacin HCL 250 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of September 1, 2022. The contract is a firm fixed-price, open competition award with no set-aside designation. Amerisourcebergen is a major...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,561,806 units of Ciprofloxacin HCL 500 mg tablets. The $2,278.13 firm fixed-price Delivery Order was awarded by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA) Troop Support, to support the Department of Defense (DoD). Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FK2E1
    Delivery Order

This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:58 AM